ARTICLE | Product Development

Animal studies show Sinovac’s COVID-19 vaccine is protective, does not cause ADE

BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.

April 22, 2020 1:40 AM UTC
Updated on Apr 23, 2020 at 12:04 PM UTC

Less than one week after entering the clinic, Sinovac became the first company to report animal data supporting its COVID-19 vaccine candidate.

Sinovac Biotech Ltd. (NASDAQ:SVA) has PiCoVacc in a Phase I/II study and expects to start Phase III testing this year. ...

BCIQ Company Profiles

Sinovac Biotech Ltd.